Reassessing Surgical Strategy After MARS 2: A Focused Critical Review.
Batna Journal of Medical Sciences (BJMS) · 01.07.2026 · 13 (7)
DOI: 10.48087/bjms.2026.130721 ↗Kurz gefasst
Fachartikel in der Zeitschrift Batna Journal of Medical Sciences (BJMS), online erschienen am 01.07.2026.
Abstract (Originalsprache)
The MARS 2 trial is a landmark phase III randomized study comparing extended pleurectomy/decortication plus chemotherapy with chemotherapy alone in malignant pleural mesothelioma (MPM).In its final report, the surgical strategy was associated with shorter survival, a higher rate of serious adverse events, and worse outcomes in terms of quality of life and cost-effectiveness.These findings are directly relevant to contemporary thoracic oncology practice and should inform discussions of surgery with patients and multidisciplinary teams.This focused critical review examines MARS 2 through its final randomized report, the trial protocol, prior randomized studies of mesothelioma surgery, major international guidelines, and selected postpublication commentary identified through a targeted review of indexed literature and guidelines up to March 2026.Post-publication correspondence and thoracic surgical commentary are considered primarily to identify recurring concerns regarding applicability and external validity, rather than as evidentiary equivalents to randomized data.The available level I evidence does not support the routine use of extended pleurectomy/decortication within the treatment pathway evaluated in MARS 2. At the same time, the trial should not be reduced to an oversimplified "no surgery ever" message, as the remaining uncertainties relate to generalizability rather than to a reversal of the main randomized findings.The most appropriate interpretation is therefore both practice-changing and methodologically rigorous: strengthening evidence-based patient counseling in the present, while guiding the design of more precise future trials in carefully staged and highly selected populations.
Zitieren
APA
(2026). Reassessing Surgical Strategy After MARS 2: A Focused Critical Review. Batna Journal of Medical Sciences (BJMS), 13(7). https://doi.org/10.48087/bjms.2026.130721
Vancouver
Reassessing Surgical Strategy After MARS 2: A Focused Critical Review. Batna Journal of Medical Sciences (BJMS). 2026;13(7). doi:10.48087/bjms.2026.130721
BibTeX
@article{euvimed2026,
title = {Reassessing Surgical Strategy After MARS 2: A Focused Critical Review},
journal = {Batna Journal of Medical Sciences (BJMS)},
year = {2026},
volume = {13},
number = {7},
doi = {10.48087/bjms.2026.130721}
}
EUVIMED